MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKernan, R. M.
Right arrow Articles by Broughton, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKernan, R. M.
Right arrow Articles by Broughton, H.

Vol. 54, Issue 1, 33-43, July 1998

Photoaffinity Labeling of the Benzodiazepine Binding Site of alpha 1beta 3gamma 2 gamma -Aminobutyric AcidA Receptors with Flunitrazepam Identifies a Subset of Ligands that Interact Directly with His102 of the alpha  Subunit and Predicts Orientation of These within the Benzodiazepine Pharmacophore

Ruth M. McKernan, Sophie Farrar, Ian Collins, Frances Emms, Ayodeji Asuni, Kathleen Quirk, and Howard Broughton

Departments of Biochemistry (R.M.M., S.F., F.E., A.A., K.Q.) and Chemistry (I.C., H.B.), Merck Sharp and Dohme Research Laboratories, Harlow, Essex, UK CM2O 2QR

Photoincorporation of ligands into the benzodiazepine site of native gamma -aminobutyric acidA (GABAA) receptors provides useful information about the nature of the benzodiazepine (BZ) binding site. Photoincorporation of flunitrazepam into a single population of GABAA receptors, recombinant human alpha 1beta 3gamma 2, was investigated to probe further the mechanism and orientation of flunitrazepam and other ligands in the BZ binding site. It was concluded that the receptor is primarily derivatized with the entire, unfragmented, flunitrazepam molecule, which undergoes a conformational change during photolysis and largely vacates the benzodiazepine binding site. Investigation of the BZ site after photoincorporation of [3H]flunitrazepam confirmed that binding of other radioligands was unaffected by incorporation of flunitrazepam. This did not correlate with their efficacy but depended on the presence of particular structural features in the molecule. It was observed that affected compounds have a pendant phenyl moiety, analogous to the 5-phenyl group of flunitrazepam, which are proposed to overlap and interact with the same residue or residues in the BZ binding site. Because the major site of flunitrazepam photoincorporation has been shown to be His102, we propose that this group of compounds interacts directly with His 102, whereas compounds of other structural types have no direct interaction with this amino acid. The orientation of ligands within the BZ binding site and their specific interaction with identified amino acids are not well understood. The data in the current study indicate that His102 interacts directly with the pendant phenyl group of diazepam, and further implications for the pharmacophore of the BZ binding site are discussed.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
F. Sancar, S. S. Ericksen, A. M. Kucken, J. A. Teissere, and C. Czajkowski
Structural Determinants for High-Affinity Zolpidem Binding to GABA-A receptors
Mol. Pharmacol., January 1, 2007; 71(1): 38 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Berezhnoy, Y. Nyfeler, A. Gonthier, H. Schwob, M. Goeldner, and E. Sigel
On the Benzodiazepine Binding Pocket in GABAA Receptors
J. Biol. Chem., January 30, 2004; 279(5): 3160 - 3168.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Sawyer, D. C. Chiara, R. W. Olsen, and J. B. Cohen
Identification of the Bovine gamma -Aminobutyric Acid Type A Receptor alpha Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513
J. Biol. Chem., December 13, 2002; 277(51): 50036 - 50045.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Teissere and C. Czajkowski
A {beta}-Strand in the {gamma}2 Subunit Lines the Benzodiazepine Binding Site of the GABAA Receptor: Structural Rearrangements Detected during Channel Gating
J. Neurosci., July 15, 2001; 21(14): 4977 - 4986.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Davies, J. G. Newell, J. M. C. Derry, I. L. Martin, and S. M. J. Dunn
Characterization of the Interaction of Zopiclone with gamma -Aminobutyric Acid Type A Receptors
Mol. Pharmacol., October 1, 2000; 58(4): 756 - 762.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. M. Kucken, D. A. Wagner, P. R. Ward, J. A. Teissére, A. J. Boileau, and C. Czajkowski
Identification of Benzodiazepine Binding Site Residues in the gamma 2 Subunit of the gamma -Aminobutyric AcidA Receptor
Mol. Pharmacol., May 1, 2000; 57(5): 932 - 939.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. M. J. Dunn, M. Davies, A. L. Muntoni, and J. J. Lambert
Mutagenesis of the Rat alpha 1 Subunit of the gamma -Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
Mol. Pharmacol., October 1, 1999; 56(4): 768 - 774.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Renard, A. Olivier, P. Granger, P. Avenet, D. Graham, M. Sevrin, P. George, and F. Besnard
Structural Elements of the gamma -Aminobutyric Acid Type A Receptor Conferring Subtype Selectivity for Benzodiazepine Site Ligands
J. Biol. Chem., May 7, 1999; 274(19): 13370 - 13374.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Sigel, M. T. Schaerer, A. Buhr, and R. Baur
The Benzodiazepine Binding Pocket of Recombinant alpha 1beta 2gamma 2 gamma -Aminobutyric AcidA Receptors: Relative Orientation of Ligands and Amino Acid Side Chains
Mol. Pharmacol., December 1, 1998; 54(6): 1097 - 1105.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics